Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database
Open Access
- 9 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Musculoskeletal Disorders
- Vol. 22 (1), 1-8
- https://doi.org/10.1186/s12891-021-04414-2
Abstract
Background The prognosis of lung metastasis (LM) in patients with chondrosarcoma was poor. The aim of this study was to construct a prognostic nomogram to predict the risk of LM, which was imperative and helpful for clinical diagnosis and treatment. Methods Data of all chondrosarcoma patients diagnosed between 2010 and 2016 was queried from the Surveillance, Epidemiology, and End Results (SEER) database. In this retrospective study, a total of 944 patients were enrolled and randomly splitting into training sets (n = 644) and validation cohorts(n = 280) at a ratio of 7:3. Univariate and multivariable logistic regression analyses were performed to identify the prognostic nomogram. The predictive ability of the nomogram model was assessed by calibration plots and receiver operating characteristics (ROCs) curve, while decision curve analysis (DCA) and clinical impact curve (CIC) were applied to measure predictive accuracy and clinical practice. Moreover, the nomogram was validated by the internal cohort. Results Five independent risk factors including age, sex, marital, tumor size, and lymph node involvement were identified by univariate and multivariable logistic regression. Calibration plots indicated great discrimination power of nomogram, while DCA and CIC presented that the nomogram had great clinical utility. In addition, receiver operating characteristics (ROCs) curve provided a predictive ability in the training sets (AUC = 0.789, 95% confidence interval [CI] 0.789–0.808) and the validation cohorts (AUC = 0.796, 95% confidence interval [CI] 0.744–0.841). Conclusion In our study, the nomogram accurately predicted risk factors of LM in patients with chondrosarcoma, which may guide surgeons and oncologists to optimize individual treatment and make a better clinical decisions. Trial registration JOSR-D-20-02045, 29 Dec 2020.This publication has 33 references indexed in Scilit:
- Chondrosarcoma of BonePublished by Springer Science and Business Media LLC ,2014
- Outcome of advanced, unresectable conventional central chondrosarcomaCancer, 2014
- Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry dataBMJ Open, 2012
- Survival and prognostic factors in chondrosarcomaActa Orthopaedica, 2011
- Chondrosarcoma of the bone with nodal metastasis: The first case report with review of literatureIndian Journal of Medical Sciences, 2011
- Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER DatabaseJournal of Bone and Joint Surgery, 2009
- The Clinical Approach Towards ChondrosarcomaThe Oncologist, 2008
- No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971–1990Acta Orthopaedica, 2003
- Chondroma and ChondrosarcomaSeminars in Thoracic and Cardiovascular Surgery, 1999
- Extraskeletal Myxoid Chondrosarcoma Long-Term Experience with ChemotherapyAmerican Journal of Clinical Oncology, 1995